Image (C456714b 707d 4449 B114 De5329846b94 01)
Brimonidine Tartrate And Timolol Maleate Solution/ Drops
Product Images NDC 70069-652
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate And Timolol Maleate (NDC 70069-652). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (C456714b 707d 4449 B114 De5329846b94 02)
Image (C456714b 707d 4449 B114 De5329846b94 03)
This is a description of an ophthalmic solution containing brimonidine tartrate (0.2%) and timolol (0.5%). The solution is preserved with benzalkonium chloride (0.005%). It should be stored at 15° - 25°C (59° - 77°F) and protected from light. The bottle is filled to half capacity and the usual dosage should be referred to the package insert for guidance. This solution is sterile and comes in a 5mL bottle, and the manufacturer is Somerset Therapeutics, LLC.*
Image (C456714b 707d 4449 B114 De5329846b94 04)
This text provides information about a prescription ophthalmic solution containing Brimonidine Tartrate and Timolol Maleate. It includes details such as the manufacturer, customer care number, ingredients, dosage instructions, storage recommendations, and NDC number. The solution is sterile and comes in a 5mL bottle. It is indicated for ophthalmic use and should be stored at a temperature between 15° - 25°C.*
Image (C456714b 707d 4449 B114 De5329846b94 05)
This is a description of an ophthalmic solution containing brimonidine tartrate 0.2% and timolol 0.5%. The usual dosage is one drop twice daily in the affected eye(s). It is preserved with benzalkonium chloride (0.005%) and should be stored at 15° - 25°C (59° - 77°F) away from light. The solution is manufactured for Somerset Therapeutics, LLC and made in India. It is sterile and comes in a 10 mL container. The NDC (National Drug Code) for this product is 70069-652-01.*
Image (C456714b 707d 4449 B114 De5329846b94 06)
This is a description of Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, a prescription eye drop manufactured for Somerset Therapeutics, LLC in Somerset, NJ. The solution contains brimonidine tartrate (0.2%) and timolol maleate (0.5%) as active ingredients, with benzalkonium chloride (0.005%) as a preservative. It is used to treat eye conditions and should be administered as one drop twice daily in the affected eye(s). The product is sterile and comes in a 10 mL bottle. It should be stored between 59°F - 77°F (15°C - 25°C) and protected from light.*
Image (C456714b 707d 4449 B114 De5329846b94 07)
This text appears to be a medication label containing information about the active ingredients, prescription status, dosage instructions, preservative content, manufacturer details, storage conditions, and product details. The medication contains brimonidine tartrate, brimonidine, and timolol. The recommended dosage is one drop in the affected eye(s) twice daily. The preservative used is benzalkonium chloride. The medication comes in a 15 mL sterile container. Storage is recommended at 15° - 25°C (59° - 77°F) and it should be protected from light. Additionally, there is a code number provided for the medication.*
Image (C456714b 707d 4449 B114 De5329846b94 08)
This text is a label for Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, containing active ingredients brimonidine tartrate 0.2% and timolol 0.5%. It provides information on dosage instructions, storage conditions, manufacturer details, and contains a customer care number. The solution is sterile and contains benzalkonium chloride as a preservative. The product is manufactured in India.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
